TY - JOUR
T1 - Amplatzer versus Figulla occluder for transcatheter patent foramen ovale closure
AU - Trabattoni, Daniela
AU - Gaspardone, Achille
AU - Sgueglia, Gregory Angelo
AU - Fabbiocchi, Franco
AU - Gioffrè, Gaetano
AU - Montorsi, Piero
AU - Calligaris, Giuseppe
AU - Iamele, Maria
AU - De Santis, Antonella
AU - Bartorelli, Antonio L
PY - 2016/12/20
Y1 - 2016/12/20
N2 - AIMS: To compare in a observational study acute and 12-month results of percutaneous closure of patent foramen ovale (PFO) with two occluder devices.METHODS AND RESULTS: Between June 2007 and October 2014, 406 consecutive patients (48.1±13.3 years, 243 women) underwent percutaneous PFO closure either with the Amplatzer (n=179) or the Figulla (n=227) device after a stroke or a transient ischemic attack ascribed to the PFO. A right-to- left shunt grade >1 was previously detected in all patients and atrial septal aneurysm was present in 111 (27.5%) patients. Patients were followed-up with contrast transthoracic echocardiogram and clinically at 24-hour, six-month, and twelve-months after the procedure. A high procedural success was observed in both groups. Despite a trend towards a higher incidence of acute residual shunt immediately after device deployment among Figulla occluder patients, a residual grade ≥2 right-to- left shunt was observed in 4.5% of patients, independently of the device used for PFO closure. The only difference reported after Figulla device implantation was a lower rate of supraventricular arrhythmias (9% vs. 17%, p=0.02).CONCLUSIONS: According to this two-centre study, PFO closure appears safe and effective with the Figulla occluder as well as with the Amplatzer device.
AB - AIMS: To compare in a observational study acute and 12-month results of percutaneous closure of patent foramen ovale (PFO) with two occluder devices.METHODS AND RESULTS: Between June 2007 and October 2014, 406 consecutive patients (48.1±13.3 years, 243 women) underwent percutaneous PFO closure either with the Amplatzer (n=179) or the Figulla (n=227) device after a stroke or a transient ischemic attack ascribed to the PFO. A right-to- left shunt grade >1 was previously detected in all patients and atrial septal aneurysm was present in 111 (27.5%) patients. Patients were followed-up with contrast transthoracic echocardiogram and clinically at 24-hour, six-month, and twelve-months after the procedure. A high procedural success was observed in both groups. Despite a trend towards a higher incidence of acute residual shunt immediately after device deployment among Figulla occluder patients, a residual grade ≥2 right-to- left shunt was observed in 4.5% of patients, independently of the device used for PFO closure. The only difference reported after Figulla device implantation was a lower rate of supraventricular arrhythmias (9% vs. 17%, p=0.02).CONCLUSIONS: According to this two-centre study, PFO closure appears safe and effective with the Figulla occluder as well as with the Amplatzer device.
KW - Journal Article
U2 - 10.4244/EIJ-D-15-00499
DO - 10.4244/EIJ-D-15-00499
M3 - Article
C2 - 27993750
JO - EuroIntervention
JF - EuroIntervention
SN - 1774-024X
ER -